Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.5400
0.00 (0.00%)
At close: Oct 5, 2026
Cambium Bio Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Cash & Equivalents | 1.12 | 0.17 | 2.86 | 0.3 |
Cash & Short-Term Investments | 1.12 | 0.17 | 2.86 | 0.3 |
Cash Growth | 570.75% | -94.19% | 846.18% | - |
Accounts Receivable | 0.16 | 0.26 | 0.26 | - |
Other Receivables | 0.01 | 0.01 | 0.02 | 0.39 |
Receivables | 0.17 | 0.28 | 0.28 | 0.39 |
Prepaid Expenses | 0.02 | 0.03 | 0.06 | 0.02 |
Other Current Assets | - | - | - | 1.75 |
Total Current Assets | 1.31 | 0.47 | 3.2 | 2.46 |
Property, Plant & Equipment | - | - | - | 0 |
Long-Term Investments | 0 | 0.38 | 0 | - |
Other Intangible Assets | 2.45 | 2.45 | 2.45 | - |
Other Long-Term Assets | 0 | 0 | - | - |
Total Assets | 3.76 | 3.3 | 5.65 | 2.46 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Accounts Payable | 1 | 0.6 | 1.22 | 0.26 |
Accrued Expenses | 0.21 | 0.37 | 1.18 | 0.17 |
Short-Term Debt | - | - | - | 0.35 |
Current Portion of Long-Term Debt | 0.15 | 0.32 | - | - |
Other Current Liabilities | 0.02 | 0.01 | 0.01 | 1.82 |
Total Current Liabilities | 1.38 | 1.29 | 2.4 | 2.59 |
Long-Term Debt | - | 0.17 | 0.47 | - |
Total Liabilities | 1.38 | 1.46 | 2.87 | 2.59 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Common Stock | 51.1 | 46.54 | 43.63 | 38.62 |
Retained Earnings | -49.21 | -46.59 | -42.75 | -40.59 |
Comprehensive Income & Other | 0.49 | 1.89 | 1.89 | 1.84 |
Shareholders' Equity | 2.38 | 1.84 | 2.78 | -0.12 |
Total Liabilities & Equity | 3.76 | 3.3 | 5.65 | 2.46 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
Total Debt | 0.15 | 0.48 | 0.47 | 0.35 |
Net Cash (Debt) | 0.97 | -0.32 | 2.4 | -0.04 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | 0.04 | -0.02 | 0.57 | -0.01 |
Filing Date Shares Outstanding | 29.43 | 18.28 | 11.93 | 3.06 |
Total Common Shares Outstanding | 27.33 | 18.28 | 11.93 | 3.06 |
Working Capital | -0.07 | -0.83 | 0.8 | -0.13 |
Book Value Per Share | 0.09 | 0.10 | 0.23 | -0.04 |
Tangible Book Value | -0.07 | -0.61 | 0.33 | -0.12 |
Tangible Book Value Per Share | -0.00 | -0.03 | 0.03 | -0.04 |
Machinery | - | - | - | 0.04 |